Presented by: Gabor Fari, Co-Founder and Principal, InteliNotion

Overview

The biopharma industry operates in a highly regulated environment with constantly evolving guidelines. To navigate this landscape, leveraging advanced technologies is essential for streamlining content creation and ensuring compliance. Generative AI (GenAI) is proving to be a transformative tool, revolutionizing content generation, regulatory information management, and submission processes. However, the effectiveness and accuracy of GenAI hinge on the quality and structure of the underlying content and data. Structured content management (SCM) is crucial in providing high-quality, standardized, structured content and data. As sponsors assess the business cost benefits and value of SCM and structured content authoring (SCA) combined with GenAI, it becomes clear that integrating these technologies offers substantial advantages.

This Webinar will explore the significant business benefits of implementing structured content within GenAI frameworks for regulatory content generation and management. By organizing content into a structured format, pharmaceutical companies can achieve enhanced accuracy, efficiency, and innovation. This integration improves content creation, regulatory compliance, and submission strategies. Structured content not only amplifies the capabilities of GenAI but also enhances information management and governance, enabling pharmaceutical companies to unlock new opportunities and maintain a competitive edge in a rapidly evolving market.